A proof-of-concept study on the genomic evolution of Sars-Cov-2 in molnupiravir-treated, paxlovid-treated and drug-naïve patients

A proof-of-concept study on the genomic evolution of SARS-CoV-2 during antiviral treatment reveals that Molnupiravir induces a higher in vivo intra-host variability compared to Paxlovid and drug-naive.

Bibliographic Details
Main Authors: Claudia Alteri, Valeria Fox, Rossana Scutari, Giulia Jole Burastero, Sara Volpi, Matteo Faltoni, Vanessa Fini, Annarita Granaglia, Sara Esperti, Altea Gallerani, Valentino Costabile, Beatrice Fontana, Erica Franceschini, Marianna Meschiari, Andrea Campana, Stefania Bernardi, Alberto Villani, Paola Bernaschi, Cristina Russo, Giovanni Guaraldi, Cristina Mussini, Carlo Federico Perno
Format: Article
Language:English
Published: Nature Portfolio 2022-12-01
Series:Communications Biology
Online Access:https://doi.org/10.1038/s42003-022-04322-8
_version_ 1828164785630347264
author Claudia Alteri
Valeria Fox
Rossana Scutari
Giulia Jole Burastero
Sara Volpi
Matteo Faltoni
Vanessa Fini
Annarita Granaglia
Sara Esperti
Altea Gallerani
Valentino Costabile
Beatrice Fontana
Erica Franceschini
Marianna Meschiari
Andrea Campana
Stefania Bernardi
Alberto Villani
Paola Bernaschi
Cristina Russo
Giovanni Guaraldi
Cristina Mussini
Carlo Federico Perno
author_facet Claudia Alteri
Valeria Fox
Rossana Scutari
Giulia Jole Burastero
Sara Volpi
Matteo Faltoni
Vanessa Fini
Annarita Granaglia
Sara Esperti
Altea Gallerani
Valentino Costabile
Beatrice Fontana
Erica Franceschini
Marianna Meschiari
Andrea Campana
Stefania Bernardi
Alberto Villani
Paola Bernaschi
Cristina Russo
Giovanni Guaraldi
Cristina Mussini
Carlo Federico Perno
author_sort Claudia Alteri
collection DOAJ
description A proof-of-concept study on the genomic evolution of SARS-CoV-2 during antiviral treatment reveals that Molnupiravir induces a higher in vivo intra-host variability compared to Paxlovid and drug-naive.
first_indexed 2024-04-12T01:32:24Z
format Article
id doaj.art-d3d48f1280234ca4a779a922ba81a3d6
institution Directory Open Access Journal
issn 2399-3642
language English
last_indexed 2024-04-12T01:32:24Z
publishDate 2022-12-01
publisher Nature Portfolio
record_format Article
series Communications Biology
spelling doaj.art-d3d48f1280234ca4a779a922ba81a3d62022-12-22T03:53:27ZengNature PortfolioCommunications Biology2399-36422022-12-015111210.1038/s42003-022-04322-8A proof-of-concept study on the genomic evolution of Sars-Cov-2 in molnupiravir-treated, paxlovid-treated and drug-naïve patientsClaudia Alteri0Valeria Fox1Rossana Scutari2Giulia Jole Burastero3Sara Volpi4Matteo Faltoni5Vanessa Fini6Annarita Granaglia7Sara Esperti8Altea Gallerani9Valentino Costabile10Beatrice Fontana11Erica Franceschini12Marianna Meschiari13Andrea Campana14Stefania Bernardi15Alberto Villani16Paola Bernaschi17Cristina Russo18Giovanni Guaraldi19Cristina Mussini20Carlo Federico Perno21Multimodal Research Area, Microbiology and Diagnostics of Immunology Unit, Bambino Gesù Children Hospital IRCCSMultimodal Research Area, Microbiology and Diagnostics of Immunology Unit, Bambino Gesù Children Hospital IRCCSMultimodal Research Area, Microbiology and Diagnostics of Immunology Unit, Bambino Gesù Children Hospital IRCCSDepartment of Infectious Diseases, University of Modena and Reggio EmiliaDepartment of Infectious Diseases, University of Modena and Reggio EmiliaDepartment of Infectious Diseases, University of Modena and Reggio EmiliaMultimodal Research Area, Microbiology and Diagnostics of Immunology Unit, Bambino Gesù Children Hospital IRCCSMultimodal Research Area, Microbiology and Diagnostics of Immunology Unit, Bambino Gesù Children Hospital IRCCSDepartment of Infectious Diseases, University of Modena and Reggio EmiliaDepartment of Infectious Diseases, University of Modena and Reggio EmiliaMultimodal Research Area, Microbiology and Diagnostics of Immunology Unit, Bambino Gesù Children Hospital IRCCSDepartment of Infectious Diseases, University of Modena and Reggio EmiliaDepartment of Infectious Diseases, AOU ModenaDepartment of Infectious Diseases, AOU ModenaAcademic Department of Pediatrics, Bambino Gesù Children’s Hospital IRCCSAcademic Department of Pediatrics, Bambino Gesù Children’s Hospital IRCCSAcademic Department of Pediatrics, Bambino Gesù Children’s Hospital IRCCSMultimodal Research Area, Microbiology and Diagnostics of Immunology Unit, Bambino Gesù Children Hospital IRCCSMultimodal Research Area, Microbiology and Diagnostics of Immunology Unit, Bambino Gesù Children Hospital IRCCSDepartment of Infectious Diseases, University of Modena and Reggio EmiliaDepartment of Infectious Diseases, University of Modena and Reggio EmiliaMultimodal Research Area, Microbiology and Diagnostics of Immunology Unit, Bambino Gesù Children Hospital IRCCSA proof-of-concept study on the genomic evolution of SARS-CoV-2 during antiviral treatment reveals that Molnupiravir induces a higher in vivo intra-host variability compared to Paxlovid and drug-naive.https://doi.org/10.1038/s42003-022-04322-8
spellingShingle Claudia Alteri
Valeria Fox
Rossana Scutari
Giulia Jole Burastero
Sara Volpi
Matteo Faltoni
Vanessa Fini
Annarita Granaglia
Sara Esperti
Altea Gallerani
Valentino Costabile
Beatrice Fontana
Erica Franceschini
Marianna Meschiari
Andrea Campana
Stefania Bernardi
Alberto Villani
Paola Bernaschi
Cristina Russo
Giovanni Guaraldi
Cristina Mussini
Carlo Federico Perno
A proof-of-concept study on the genomic evolution of Sars-Cov-2 in molnupiravir-treated, paxlovid-treated and drug-naïve patients
Communications Biology
title A proof-of-concept study on the genomic evolution of Sars-Cov-2 in molnupiravir-treated, paxlovid-treated and drug-naïve patients
title_full A proof-of-concept study on the genomic evolution of Sars-Cov-2 in molnupiravir-treated, paxlovid-treated and drug-naïve patients
title_fullStr A proof-of-concept study on the genomic evolution of Sars-Cov-2 in molnupiravir-treated, paxlovid-treated and drug-naïve patients
title_full_unstemmed A proof-of-concept study on the genomic evolution of Sars-Cov-2 in molnupiravir-treated, paxlovid-treated and drug-naïve patients
title_short A proof-of-concept study on the genomic evolution of Sars-Cov-2 in molnupiravir-treated, paxlovid-treated and drug-naïve patients
title_sort proof of concept study on the genomic evolution of sars cov 2 in molnupiravir treated paxlovid treated and drug naive patients
url https://doi.org/10.1038/s42003-022-04322-8
work_keys_str_mv AT claudiaalteri aproofofconceptstudyonthegenomicevolutionofsarscov2inmolnupiravirtreatedpaxlovidtreatedanddrugnaivepatients
AT valeriafox aproofofconceptstudyonthegenomicevolutionofsarscov2inmolnupiravirtreatedpaxlovidtreatedanddrugnaivepatients
AT rossanascutari aproofofconceptstudyonthegenomicevolutionofsarscov2inmolnupiravirtreatedpaxlovidtreatedanddrugnaivepatients
AT giuliajoleburastero aproofofconceptstudyonthegenomicevolutionofsarscov2inmolnupiravirtreatedpaxlovidtreatedanddrugnaivepatients
AT saravolpi aproofofconceptstudyonthegenomicevolutionofsarscov2inmolnupiravirtreatedpaxlovidtreatedanddrugnaivepatients
AT matteofaltoni aproofofconceptstudyonthegenomicevolutionofsarscov2inmolnupiravirtreatedpaxlovidtreatedanddrugnaivepatients
AT vanessafini aproofofconceptstudyonthegenomicevolutionofsarscov2inmolnupiravirtreatedpaxlovidtreatedanddrugnaivepatients
AT annaritagranaglia aproofofconceptstudyonthegenomicevolutionofsarscov2inmolnupiravirtreatedpaxlovidtreatedanddrugnaivepatients
AT saraesperti aproofofconceptstudyonthegenomicevolutionofsarscov2inmolnupiravirtreatedpaxlovidtreatedanddrugnaivepatients
AT alteagallerani aproofofconceptstudyonthegenomicevolutionofsarscov2inmolnupiravirtreatedpaxlovidtreatedanddrugnaivepatients
AT valentinocostabile aproofofconceptstudyonthegenomicevolutionofsarscov2inmolnupiravirtreatedpaxlovidtreatedanddrugnaivepatients
AT beatricefontana aproofofconceptstudyonthegenomicevolutionofsarscov2inmolnupiravirtreatedpaxlovidtreatedanddrugnaivepatients
AT ericafranceschini aproofofconceptstudyonthegenomicevolutionofsarscov2inmolnupiravirtreatedpaxlovidtreatedanddrugnaivepatients
AT mariannameschiari aproofofconceptstudyonthegenomicevolutionofsarscov2inmolnupiravirtreatedpaxlovidtreatedanddrugnaivepatients
AT andreacampana aproofofconceptstudyonthegenomicevolutionofsarscov2inmolnupiravirtreatedpaxlovidtreatedanddrugnaivepatients
AT stefaniabernardi aproofofconceptstudyonthegenomicevolutionofsarscov2inmolnupiravirtreatedpaxlovidtreatedanddrugnaivepatients
AT albertovillani aproofofconceptstudyonthegenomicevolutionofsarscov2inmolnupiravirtreatedpaxlovidtreatedanddrugnaivepatients
AT paolabernaschi aproofofconceptstudyonthegenomicevolutionofsarscov2inmolnupiravirtreatedpaxlovidtreatedanddrugnaivepatients
AT cristinarusso aproofofconceptstudyonthegenomicevolutionofsarscov2inmolnupiravirtreatedpaxlovidtreatedanddrugnaivepatients
AT giovanniguaraldi aproofofconceptstudyonthegenomicevolutionofsarscov2inmolnupiravirtreatedpaxlovidtreatedanddrugnaivepatients
AT cristinamussini aproofofconceptstudyonthegenomicevolutionofsarscov2inmolnupiravirtreatedpaxlovidtreatedanddrugnaivepatients
AT carlofedericoperno aproofofconceptstudyonthegenomicevolutionofsarscov2inmolnupiravirtreatedpaxlovidtreatedanddrugnaivepatients
AT claudiaalteri proofofconceptstudyonthegenomicevolutionofsarscov2inmolnupiravirtreatedpaxlovidtreatedanddrugnaivepatients
AT valeriafox proofofconceptstudyonthegenomicevolutionofsarscov2inmolnupiravirtreatedpaxlovidtreatedanddrugnaivepatients
AT rossanascutari proofofconceptstudyonthegenomicevolutionofsarscov2inmolnupiravirtreatedpaxlovidtreatedanddrugnaivepatients
AT giuliajoleburastero proofofconceptstudyonthegenomicevolutionofsarscov2inmolnupiravirtreatedpaxlovidtreatedanddrugnaivepatients
AT saravolpi proofofconceptstudyonthegenomicevolutionofsarscov2inmolnupiravirtreatedpaxlovidtreatedanddrugnaivepatients
AT matteofaltoni proofofconceptstudyonthegenomicevolutionofsarscov2inmolnupiravirtreatedpaxlovidtreatedanddrugnaivepatients
AT vanessafini proofofconceptstudyonthegenomicevolutionofsarscov2inmolnupiravirtreatedpaxlovidtreatedanddrugnaivepatients
AT annaritagranaglia proofofconceptstudyonthegenomicevolutionofsarscov2inmolnupiravirtreatedpaxlovidtreatedanddrugnaivepatients
AT saraesperti proofofconceptstudyonthegenomicevolutionofsarscov2inmolnupiravirtreatedpaxlovidtreatedanddrugnaivepatients
AT alteagallerani proofofconceptstudyonthegenomicevolutionofsarscov2inmolnupiravirtreatedpaxlovidtreatedanddrugnaivepatients
AT valentinocostabile proofofconceptstudyonthegenomicevolutionofsarscov2inmolnupiravirtreatedpaxlovidtreatedanddrugnaivepatients
AT beatricefontana proofofconceptstudyonthegenomicevolutionofsarscov2inmolnupiravirtreatedpaxlovidtreatedanddrugnaivepatients
AT ericafranceschini proofofconceptstudyonthegenomicevolutionofsarscov2inmolnupiravirtreatedpaxlovidtreatedanddrugnaivepatients
AT mariannameschiari proofofconceptstudyonthegenomicevolutionofsarscov2inmolnupiravirtreatedpaxlovidtreatedanddrugnaivepatients
AT andreacampana proofofconceptstudyonthegenomicevolutionofsarscov2inmolnupiravirtreatedpaxlovidtreatedanddrugnaivepatients
AT stefaniabernardi proofofconceptstudyonthegenomicevolutionofsarscov2inmolnupiravirtreatedpaxlovidtreatedanddrugnaivepatients
AT albertovillani proofofconceptstudyonthegenomicevolutionofsarscov2inmolnupiravirtreatedpaxlovidtreatedanddrugnaivepatients
AT paolabernaschi proofofconceptstudyonthegenomicevolutionofsarscov2inmolnupiravirtreatedpaxlovidtreatedanddrugnaivepatients
AT cristinarusso proofofconceptstudyonthegenomicevolutionofsarscov2inmolnupiravirtreatedpaxlovidtreatedanddrugnaivepatients
AT giovanniguaraldi proofofconceptstudyonthegenomicevolutionofsarscov2inmolnupiravirtreatedpaxlovidtreatedanddrugnaivepatients
AT cristinamussini proofofconceptstudyonthegenomicevolutionofsarscov2inmolnupiravirtreatedpaxlovidtreatedanddrugnaivepatients
AT carlofedericoperno proofofconceptstudyonthegenomicevolutionofsarscov2inmolnupiravirtreatedpaxlovidtreatedanddrugnaivepatients